publicationMetadata:
  pmid: "37328102"
  title: "Inhibition of Erb-B2 Receptor Tyrosine Kinase 3 and Associated Regulatory Pathways Potently Impairs Malignant Peripheral Nerve Sheath Tumor Proliferation and Survival"
  queryType: "unknown"
  publicationType: "Lab Research"
  publicationTypeConfidence: 0.9
  hasMethodsSection: No
  likelyContainsTools: Yes
  expectedToolTypes: |
    Based on the abstract content, this is clearly a laboratory research study investigating MPNST 
    (Malignant Peripheral Nerve Sheath Tumor) biology and therapeutic targets. Expected tool types include:
    - Cell lines: MPNST cell lines and Schwann cells are explicitly mentioned
    - Genetic reagents: shRNA screens and erbB3 knockdown are described
    - Computational tools: Kinomic and microarray analyses are mentioned
    - Chemical compounds: Multiple drug inhibitors are tested (canertinib, sapitinib, saracatinib, AZD1208, trifluoperazine)
    
    The study involves experimental manipulation of cell lines, genetic knockdown experiments, 
    drug treatments, and molecular analyses - all indicating active laboratory research with multiple tool types.
  overallAssessment: |
    This publication represents active laboratory research investigating therapeutic targets in MPNST. 
    The abstract describes experimental work including cell culture, genetic manipulation (shRNA, knockdown), 
    drug treatments, and molecular analyses (kinomic, microarray). Despite lacking a Methods section in 
    the extracted content, the abstract clearly indicates extensive use of research tools that should have 
    been captured by mining algorithms. The absence of mined tools suggests significant gaps in the mining process.

toolValidations: []

potentiallyMissedTools:
  - toolName: "MPNST cell lines"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "...erbB3 is commonly expressed in MPNSTs and MPNST cell lines and that erbB3 knockdown inhibits MPNST proliferation..."
    whyMissed: "Generic reference to 'MPNST cell lines' without specific cell line names or identifiers"
    confidence: 0.8
    shouldBeAdded: Yes

  - toolName: "Schwann cells"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "...Kinomic and microarray analyses of Schwann and MPNST cells implicate Src- and erbB3-mediated..."
    whyMissed: "Primary cell type mentioned in experimental context but may be considered too generic"
    confidence: 0.7
    shouldBeAdded: Maybe

  - toolName: "shRNA screens"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...previous studies used genome-scale shRNA screens that implicated the neuregulin-1 receptor..."
    whyMissed: "Mentioned as methodology from previous studies, not current study usage"
    confidence: 0.6
    shouldBeAdded: Maybe

  - toolName: "erbB3 knockdown"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...erbB3 knockdown inhibits MPNST proliferation and survival...erbB3 knockdown in combination with..."
    whyMissed: "Genetic manipulation technique mentioned but not recognized as a specific reagent"
    confidence: 0.8
    shouldBeAdded: Yes

  - toolName: "kinomic analysis"
    toolType: "computational_tool"
    foundIn: "abstract"
    contextSnippet: "...Kinomic and microarray analyses of Schwann and MPNST cells implicate..."
    whyMissed: "Analytical technique that may require specific software/platforms not captured"
    confidence: 0.7
    shouldBeAdded: Yes

  - toolName: "microarray analysis"
    toolType: "computational_tool"
    foundIn: "abstract"
    contextSnippet: "...Kinomic and microarray analyses of Schwann and MPNST cells implicate..."
    whyMissed: "Common analytical technique that may not have been recognized without specific platform names"
    confidence: 0.8
    shouldBeAdded: Yes

  - toolName: "canertinib"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...inhibition of upstream (canertinib, sapitinib, saracatinib, and calmodulin) and parallel (AZD1208)..."
    whyMissed: "Chemical inhibitor used as research reagent not captured by mining patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "sapitinib"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...inhibition of upstream (canertinib, sapitinib, saracatinib, and calmodulin) and parallel (AZD1208)..."
    whyMissed: "Chemical inhibitor used as research reagent not captured by mining patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "saracatinib"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...inhibition of upstream (canertinib, sapitinib, saracatinib, and calmodulin) and parallel (AZD1208)..."
    whyMissed: "Chemical inhibitor used as research reagent not captured by mining patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "AZD1208"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...and parallel (AZD1208) signaling pathways...or proviral integration site of Moloney murine leukemia kinase (AZD1208) inhibition..."
    whyMissed: "Chemical inhibitor with specific compound identifier not captured"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "trifluoperazine"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "...calmodulin [trifluoperazine (TFP)]...when combined with TFP, it even more effectively reduces..."
    whyMissed: "Chemical compound used as calmodulin inhibitor not recognized as research reagent"
    confidence: 0.8
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "term"
    pattern: "\\b[A-Z]{2,}\\d{3,}\\b"
    toolType: "genetic_reagent"
    examples: ["AZD1208"]
    reasoning: "Pattern to capture compound identifiers with alphanumeric codes commonly used for chemical inhibitors"

  - patternType: "context_phrase"
    pattern: "knockdown|knock-down|knockdown of|silencing of"
    toolType: "genetic_reagent"
    examples: ["erbB3 knockdown"]
    reasoning: "Genetic manipulation techniques that represent specific research reagents/methods"

  - patternType: "context_phrase"
    pattern: "kinomic analysis|kinome analysis|kinomic profiling"
    toolType: "computational_tool"
    examples: ["Kinomic and microarray analyses"]
    reasoning: "Specialized analytical techniques that require specific computational tools and platforms"

  - patternType: "context_phrase"
    pattern: "microarray analysis|microarray profiling|gene expression profiling"
    toolType: "computational_tool"
    examples: ["Kinomic and microarray analyses"]
    reasoning: "Common genomic analysis techniques that involve specific computational tools and platforms"

  - patternType: "naming_convention"
    pattern: "\\w+inib\\b"
    toolType: "genetic_reagent"
    examples: ["canertinib", "sapitinib"]
    reasoning: "Chemical inhibitors ending in '-inib' are commonly used research reagents in cancer research"

  - patternType: "context_phrase"
    pattern: "cell lines?\\b|cell line\\b"
    toolType: "cell_line"
    examples: ["MPNST cell lines"]
    reasoning: "Direct mentions of cell lines should be captured even when specific names aren't provided"

observations: []

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 11
  newPatternsCount: 6
  observationsExtracted: 0
  observationsByType: {}
  majorIssuesFound: |
    - No tools were mined from this publication despite clear evidence of extensive laboratory research
    - Abstract describes multiple experimental approaches including cell culture, genetic manipulation, drug treatments, and molecular analyses
    - Missing Methods section limits ability to extract detailed tool information and scientific observations
    - Mining algorithms appear to have significant gaps in recognizing chemical inhibitors, genetic reagents, and analytical techniques
    - At least 11 potential research tools were identified in the abstract alone that should have been captured
  recommendations: |
    - All potentially missed tools should be manually reviewed and likely added to the database
    - Mining patterns need significant enhancement to capture chemical inhibitors, genetic manipulation techniques, and analytical methods
    - Consider developing patterns for compound identifiers (e.g., AZD1208) and drug names ending in common suffixes (-inib)
    - Improve recognition of experimental techniques as computational tools (kinomic analysis, microarray analysis)
    - The absence of full text sections (Methods, Results, Discussion) severely limits tool extraction and observation capture
    - This publication represents a clear case where mining algorithms failed to identify obvious research tools
    - Recommend manual curation of this publication to capture the extensive research tools described
